Risk stratification in unstable coronary artery disease Exercise test and troponin T from a gender perspective by Säfström, Kåge et al.
Risk Stratification
in Unstable Coronary Artery Disease
Exercise Test and Troponin T from a Gender Perspective
Kåge Sa¨fstro¨m, MD,* Bertil Lindahl, PHD,† Eva Swahn, PHD,* and the FRISC-Study Group
Linko¨ping and Uppsala, Sweden
OBJECTIVES The study was done to determine the prognostic yield of an early symptom-limited exercise
test (ET) and measurement of troponin T (TnT) in men and women with unstable coronary
artery disease (CAD), with special reference to gender differences.
BACKGROUND Early risk assessment is essential for the application of appropriate treatment and further
management in patients with unstable CAD. The early symptom-limited ET together with
specific biochemical marker determination is an inexpensive, widely applicable method for
early risk stratification. In women, however, the ET is considered less reliable, and there are
few data on biochemical markers for risk stratification in women.
METHODS In a substudy of the Fragmin during InStability in Coronary artery disease (FRISC I) trial,
395 women and 778 men with unstable CAD who performed an early ET were followed for
six months. Blood samples for TnT determination were taken in 342 women and 621 men
at inclusion.
RESULTS Based on the ET results, low-, intermediate-, and high-risk response groups were identified
with event rates of cardiac death or myocardial infarction (MI) of 1%, 9%, and 19%,
respectively, among women and 8%, 14%, and 20%, respectively, among men. Patients who
could not perform the ET had an event rate similar to the high-risk group. The TnT levels
were divided into three groups: ,0.06, 0.06–0.19, and $0.20 mg/liter with event rates of 1%,
10%, and 18%, respectively, among women and 9%, 14%, and 18%, respectively, among men.
Combining the ET results with TnT levels identified a low-risk group with an event rate of
3% in the male population and no events in the female population.
CONCLUSIONS Direct comparison between men and women from the same population with a high pretest
likelihood of disease suggests that both TnT and the early symptom-limited ET are at least
as useful as prognostic risk indicators in women as they are in men. (J Am Coll Cardiol 2000;
35:1791–800) © 2000 by the American College of Cardiology
Unstable coronary artery disease (CAD) is still associated
with high mortality and morbidity despite considerable
progress in therapy. A nonocclusive thrombus is usually the
pathophysiologic mechanism behind the rapid deterioration
from stable angina to unstable angina or the development of
a non-Q-wave myocardial infarction (MI). To save myo-
cardium it is of utmost importance to prevent the vessel
from permanently occluding. In recent decades efforts have
been made to find feasible instruments for early risk strat-
ification, with the aim of intervening and eliminating or at
least postponing the risk for MI or sudden death in patients
with unstable CAD. Several studies have shown that it is
possible to reveal high-, medium-, and low-risk patients
using an early exercise test (ET), at least in men (1–4). The
diagnostic and prognostic information gained from an ET is
considered less reliable in women than in men, mostly due
to the high percentage of false-positive tests (5,6). This
may, at least partly, be due to a lower pretest likelihood
among those women studied. In a population with a lower
prevalence of a certain parameter any test for this tends to
have more false-positive results and thus a lower specificity.
For these reasons, electrocardiogram (ECG) changes in
exercise tests in the absence of CAD are more frequently
observed in women due to a lower prevalence of CAD in
most populations (i.e., when comparing age-matched pop-
ulations).
During recent years the cardiac-specific troponins have
been shown to have not only diagnostic but also prognostic
significance (7–14). However, studies have consisted of
mixed male and female, or male-dominated populations.
Thus, the aim of this study was to compare, between men
and women, the use of early symptom-limited ET and early
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troponin T (TnT) release as tools for risk stratification in a
population with a presumed high prevalence of significant
ischemic heart disease.
METHODS
Study population. The study was part of a prospective
randomized trial of low molecular weight heparin (daltepa-
rin sodium, Fragmin Pharmacia Upjohn, Sweden) in pa-
tients with unstable CAD including 1,506 patients at 23
hospitals throughout Sweden between May 1992 and Oc-
tober 1994 (15). The inclusion criteria were a history of
unstable angina or chest pain suggestive of acute MI, with
onset of the last episode of chest pain within 72 h in
conjunction with signs of ischemia in the form of transient
or persistent ST-depression of $0.1 mV in at least two
adjacent leads and/or transient or persistent T-wave inver-
sion of $0.1 mV in at least two adjacent leads. Exclusion
criteria consisted mainly of conditions with an increased risk
for bleeding and difficulties in interpreting the ECG—for
example, pacemaker rhythm or left bundle branch block
(15).
Pharmacological treatment included aspirin and beta-
blockade if not contraindicated and, as required, organic
nitrates and calcium antagonists. The patients were ran-
domly assigned to dalteparin sodium (Fragmin: 120 IU per
kg body weight) or placebo given subcutaneously twice daily
for five to seven days and then 7,500 IU or placebo once
daily for another five weeks. Other medications were given
at the discretion of the physician. All drugs were continued
during the ET. Coronary angiography and revascularization
were recommended in cases of refractory or incapacitating
angina despite optimal pharmacological treatment or signs
of severe ischemia at the ET. All therapeutic decisions were
made without knowledge of the patient’s TnT levels. Each
patient stayed in hospital during the acute phase for at least
five days. After six weeks the patients attended the outpa-
tient department. The final visit took place five to seven
months after trial inclusion. The study was approved by the
ethics committees of all participating university hospitals.
All patients provided informed consent.
The ECG and exercise test. A resting ECG (12 lead) was
taken at admission, at inclusion in the study, after 5 to 8, 40
to 50, and 150 to 210 days. Extra ECGs were obtained at
recurrence of chest pain during hospitalization, at readmis-
sion, or at unscheduled visits to the outpatient department.
All patients who were considered stable (i.e., no ECG
changes or chest pain at rest during the previous 48 h) were
to perform an ET prior to discharge at the earliest five days
and at the latest eight days after admission. The ET was
performed with the patient sitting on an electrically braked
bicycle ergometer starting at 10 to 30 W with repeated load
increases of 10 W/min. The test was terminated when
limiting symptoms occurred, such as chest pain of a degree
5/10, dyspnea of 5/10, or at exertion degree of 17/20 using
the Borg scales (16). The test was also terminated if any of
the following occurred: ST depression $0.3 mV, fall in
systolic blood pressure .15 mm Hg measured once or
10 mm Hg measured twice with a 1-min interval, or serious
arrhythmia—that is, ventricular tachycardia with three or
more ventricular beats, .5 beats of bigeminal type, or the
appearance of second- or third-degree atrioventricular
block.
A 12-lead ECG was obtained before, continuously dur-
ing, and for 10 min after the ET. Heart rate was measured
every minute and systolic blood pressure and respiratory rate
every third minute. Perceived exertion, chest pain, and
dyspnea were rated by the patient every third minute during
the test using the Borg scales; ST depression during the ET
was measured 60 ms after the J-point.
The ECG and ETs were first interpreted by the local
investigator, who also made all decisions regarding further
treatment, although the final analysis used in this report was
made centrally (Departments of Clinical Physiology, Upp-
sala and Jo¨nko¨ping) and without knowledge of patients’
diagnosis and outcome. Computer-aided systems and, thus,
averaged ECG complexes were used (Marquette Electron-
ics, Milwaukee, Wisconsin; Schiller, Switzerland; FMAB,
Partille, Sweden; Siemens Elema AB, Stockholm, Sweden).
The raw data were manually examined to confirm the
accuracy of the computer averages. An abnormal ST reac-
tion was defined as a $0.1-mV downsloping or horizontal
depression of the ST segment compared to resting ECG.
Previous studies from our group on male patients or
male-dominated populations have shown that a low maxi-
mal workload and/or the number of leads with ST-
depression $0.1 mV and/or maximal rate pressure product
are independent factors of future cardiac events (4,17) and
severity of coronary lesions (2). In accordance with previous
results (2,4,17), a combination of these factors was used to
define three risk groups: a “high-risk group” where patients
had at least two out of three criteria; an “intermediate-risk
group” with one criteria, and a “low-risk group” where
patients lacked all three criteria. The criteria were a low
maximal workload defined as a workload below the 33rd
percentile of the distribution for men (90 W) and women
(70 W), respectively; ST-depression $0.1 mV in $3 leads;
and a small increase in rate-pressure product during exercise
(heart rate 3 systolic blood pressure at peak load 2 heart
rate 3 systolic blood pressure at rest) defined as a value
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
CAD 5 coronary artery disease
ECG 5 electrocardiogram
ET 5 exercise test
MI 5 myocardial infarction
PTCA 5 percutaneous transluminal coronary
angioplasty
TnT 5 troponin T
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below the 33rd percentile of the distribution for men
(8,750) and women (8,000), respectively.
Blood samples and laboratory methods. Venous blood
samples for analysis of plasma TnT were obtained at
inclusion and then after 12, 24, 48, and 120 h. Blood was
collected in EDTA-containing tubes and was then centri-
fuged. The plasma was frozen in aliquots and stored for
subsequent analysis. Troponin T (TnT) was determined
using the Enzymun-Test system (Boeringer-Mannheim)
(18). The lower detection limit is 0.04 mg/liter according to
the manufacturer, and the upper reference level in healthy
blood donors is 0.06 mg/liter (19). All analyses were
performed at one laboratory (Department of Clinical
Chemistry, Uppsala). The between-day coefficient of vari-
ation over four months (n 5 99) at the laboratory was 10.2%
and 5.1% at a level of 0.28 and 6.10 mg/liter, respectively.
According to a previous report from the present study
(20), the maximal TnT level obtained during the first 24 h
was an independent predictor of future cardiac events
(cardiac death or MI) in patients with unstable CAD.
The addition of samples at 48 and 120 h did not improve
the prognostic value of the test. A maximal TnT value of
,0.06, 0.06 to 0.19, and $0.2 mg/liter during the first
24 h enabled stratification of the subjects into low-,
intermediate-, and high-risk groups, respectively (20).
The same cutoff values were used in the present analysis.
Evaluation of index event and end point definition. All
primary end points (i.e., death and nonfatal MI) were
classified by an independent end point committee. Great
care was taken to differentiate new events from the initial
event. At admission and at recurrence of severe chest pain,
serial blood samples for measurement of biochemical mark-
ers of MI were obtained. The episode that qualified a
patient for enrollment in the study (index event) was
classified retrospectively as acute MI or unstable angina,
based on the maximal levels of available cardiac enzymes
obtained and analyzed at the local hospital immediately
after that episode, as described in a previous report (20).
Myocardial infarction was defined by conventional WHO
criteria (21). Cause of death was based on hospital records
and, if available, necropsy reports. Sudden death was con-
sidered cardiac. If the patient had more than one event (i.e.,
MI and death) during follow-up, only the first-occurring
event was taken into consideration in the combined end
points. Readmission because of refractory angina or MI was
especially recorded.
Statistical analysis. Differences in proportions were judged
by chi-square analysis with the Yates continuity correction.
For nonparametric unrelated data, the Mann-Whitney U
test was used. Comparison of continuous variables was
performed using unpaired t-test. The cumulative hazard
curves were constructed using the Kaplan-Meier method.
End points were cardiac death or nonfatal MI. Noncardiac
death was treated as a censored observation. Statistical
assessment was performed using the log-rank test. To
identify variables of independent prognostic importance,
forward stepwise multiple logistic regression analysis was
performed regarding the predefined end points MI or
cardiac death. The cutoff value for entry into the model was
0.05. Evaluated independent variables were clinical (age;
diabetes mellitus; smoking habits; congestive heart failure;
hypertension; previous MI; enzyme release above decision
limits for MI at the initial event), number of antianginal
drugs at ET, maximum TnT during first 24 h: ,0.06; 0.06
to 0.19; $0.2 mg/liter, and ET; “low-risk”; “intermediate-
risk”; “high-risk/no ET.” As the event rate in the non-ET
group was similar to the “high-risk response group” these
two groups were considered together in the multiple regres-
sion analysis. In all tests a p value of ,0.05 was considered
statistically significant. All statistical analyses were per-
formed by a computer using the SPSS system (Statistical
Package for the Social Sciences, Chicago, Illinois).
RESULTS
An ET was performed in 1,180 patients. Seven patients
already had a new event before the test, leaving 1,173
patients for evaluation of the ET. A total of 326 patients did
not perform the ET. Forty-four of these patients were
excluded from the analysis due to an event before day
8—that is, the last day upon which the ET could be
performed. Blood samples for TnT analysis were drawn in
976 patients. Patients with events during the sampling
period and one day beyond were excluded, leaving 963
patients for TnT analyses (Fig. 1).
General findings. Women were older than men in both
the ET and non-ET groups. Previous congestive heart
failure and use of diuretics were more common among
women in each ET group (Table 1). Women had a lower
median TnT maximum than did men (0.17 vs. 0.51 mg/liter
p , 0.0001). During six months of follow-up from the ET
(or day 8 in the non-ET group) there were 22 (4.2%) and 44
Figure 1. Recruitment of the study population.
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(4.7%) deaths, 59 (11%) and 106 (11%) MIs, 167 (32%) and
339 (37%) PTCA/CABG (percutaneous transluminal cor-
onary angioplasty/coronary artery bypass graft surgery) in
women and men, respectively.
Nonexercise test group. Both men and women in the
non-ET group were older and had more often experienced
a previous stroke or MI than did patients of respective
gender in the ET group. The median TnT maximum did
not differ between the ET and non-ET group (0.32 vs. 0.34
mg/liter, p 5 NS). In the nonexercise test group, women
had significantly lower median TnT values than did men
(0.20 vs. 0.62 mg/liter, p , 0.01).
Patients who did not perform the ET (n 5 282) had
significantly more cardiac deaths in both men and women.
Women in the non-ET group had a higher incidence of the
combined end point cardiac death/MI (p , 0.001) com-
pared to women in the ET group, whereas the same did not
apply to men (Table 2).
The exercise test group. An ET was performed a median
of five days after inclusion (95% of the patients from day 4
to day 7); results are shown in Table 3. Women were older,
had less ST-depression, and reported less pain at the ET
than did men. Female subjects had lower maximum work-
load but reached the same expected maximum workload as
did men in relation to gender, body weight, and age.
The number of patients in the three prespecified risk
Table 1. Clinical Characteristics of the Study Group (n 5 1,455)
Exercise Test Group Nonexercise Test Group
Men (n 5 778) Women (n 5 395) Men (n 5 150) Women (n 5 132)
Background factors
Age 69 (60–74) 71 (64–76)*** 72 (64–77)††† 74 (68–80)**†††
Diabetes 88 (11) 56 (14) 22 (15) 30 (23)†
Current smoking 180 (23) 62 (15)** 28 (19) 21 (16)
Previous CHF 51 (7) 43 (11)* 16 (11) 30 (23)*††
Previous stroke 23 (3) 17 (4) 14 (9)††† 14 (11)†
Hypertension 226 (29) 137 (35) 48 (32) 58 (44)
History of CAD
Previous MI 213 (27) 99 (25) 58 (39)†† 55 (42)†††
Occurrence of angina at rest the preceding week 378 (49) 181 (46) 71 (47) 69 (52)
Ongoing angina at admission 418 (54) 242 (61)* 110 (73)††† 84 (64)
Inclusion diagnosis
Non-Q-wave MI 313 (40) 131 (33)* 70 (47) 46 (35)
Medication at inclusion
Aspirin 265 (34) 130 (33) 69 (46)†† 60 (46)†
Beta-blocker 267 (34) 163 (41)* 61 (41) 46 (35)
Calcium inhibitor 149 (19) 85 (22) 43 (29)† 39 (30)
Nitroglycerin prophylactic 199 (26) 112 (28) 48 (32) 55 (42)††
Diuretics 129 (17) 114 (29)*** 39 (26)†† 63 (48)***†††
Digoxin 42 (5) 29 (7) 10 (7) 19 (14)†
ACE inhibitor 62 (8) 33 (8) 20 (13)† 11 (8)
ECG at rest at inclusion
Q wave 202 (21) 71 (13)*** 37 (25) 23 (17)
ST depression 602 (63) 318 (59) 104 (69) 84 (64)
T-wave inversion 637 (81) 337 (85)* 111 (74)† 112 (85)*
CHF 5 congestive heart failure; CAD 5 coronary artery disease; MI 5 myocardial infarction. Values are median (25th to 75th percentile) or n (%).
*p , 0.05; **p , 0.01; ***p , 0.001 men vs. women within exercise test or nonexercise test groups. †p , 0.05; ††p , 0.01; †††p , 0.001 men vs. men and women vs. women
comparing the exercise test group to the nonexercise test group.
Table 2. End Points After Six-Month Follow-Up
Exercise Test Group Nonexercise Test Group
Men (n 5 778) Women (n 5 395) Men (n 5 150) Women (n 5 132)
Cardiac death 30 (4) 12 (3) 14 (9)†† 10 (8)†
Myocardial infarction 87 (11) 29 (7)* 19 (13) 17 (13)
Cardiac death/MI 104 (13) 35 (9)* 26 (17) 23 (17)††
CABG/PTCA 277 (36) 126 (32) 68 (45)† 41 (31)*
MI 5 myocardial infarction; CABG 5 coronary artery bypass grafting; PTCA 5 percutaneous transluminal coronary angioplasty. Values are n (%).
*p , 0.05 men vs. women within the same group. †p , 0.05; ††p , 0.01 men vs. men and women vs. women comparing the exercise test group to the nonexercise test group.
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response groups (low-, intermediate-, and high-) were
evenly distributed, except for women, where there were
fewer in the high-risk response group (Table 4). The TnT
values were lower for women than for men in the ET group
(0.15 vs. 0.48 mg/liter, p , 0.00001).
We found a definite low-risk response group among
women, where only 1% had a serious cardiac event (cardiac
death/MI) compared to men, where 8% had an event during
the follow-up period. In the high-risk response group,
women and men had a similar event rate of 19% and 20%,
respectively (Fig. 2A). The rate of revascularization at six
months was 36% in women and 49% in men (Table 4).
When combining all end points (cardiac death/MI/PTCA/
CABG) at six months the event rates in the high-risk
response group were 49% and 59% for women and men,
respectively, compared to 18% and 27% in the low-risk
group (p , 0.0001 for women vs. women and p , 0.001 for
men vs. men).
Troponin T. Troponin T was sampled and measured in
963 patients. During the first 24 h three samples were
obtained in 884 patients; 62 patients left two samples and in
17 patients only one sample was measured. Forty-nine
percent of the women and 64% of the men had TnT values
above the decision limit for MI ($0.20 mg/liter), which was
regarded as the high-risk group. In this group 18% of both
women and men had a serious cardiac event (cardiac
death/MI) during the follow-up compared to 1% and 9%,
respectively, in the group with TnT values ,0.06 mg/liter
(Table 4, Fig. 2B).
Exercise test and troponin T in combination. A popula-
tion of 770 patients (255 women and 515 men) performed
an ET as well as had TnT measured. Combining ET risk
response and TnT values we found that male and female
patients with low TnT values and a low risk response at the
ET had very few cardiac events during follow-up (no
women and one man). In the high-risk group (combined
ET and TnT values) the event rate was 31% and 26% in
women and men, respectively (Fig. 3).
Multivariate logistic regression analysis. Univariate and
multivariate stepwise logistic regression analyses were per-
formed to assess the value of a number of clinical variables,
findings at the predischarge ET, and maximum TnT value
in predicting cardiac events. In the multivariate analysis, the
ET was the best variable to predict cardiac death/nonfatal
MI during follow-up (Table 5).
DISCUSSION
In this population of patients admitted to hospital because
of an episode of unstable CAD we had the opportunity to
compare 928 men with 527 women regarding clinical
parameters and indices of risk. We studied a population at
high risk, as the combined end point of cardiac death/MI
was high in both men and women during the six-month
follow-up period (13.2% and 16.6% in women and men,
respectively) in the entire FRISC I (Fragmin during InSta-
bility in Coronary artery disease) population.
The women were, in general, older, had more previous
congestive heart failure, and used more diuretics than did
men. Both women and men in the non-ET group were
older, and more patients had suffered from previous cardio-
vascular disease, such as MI and stroke, than did patients in
the ET group. These patients thus constituted a group who,
in accordance with previous studies (17,22), were sicker.
Consequently, this group had a worse prognosis than the
others, regarding cardiac death in both women and men,
whereas only women had a higher incidence of the com-
bined end point cardiac death/MI (p , 0.001). Male and
female patients with unstable CAD who are not able to
Table 3. Findings at the Predischarge Symptom-Limited Exercise Test (n 5 1,173)
Men (n 5 778) Women (n 5 395)
Median (33rd to 67th percentile)
Maximum workload (W) 105 (90–120) 80 (70–90)***
% of Expected maximum workload 79 (69–89) 80 (71–90)
Maximum heart rate (beatszmin21) 111 (104–122) 113 (104–124)
Maximum blood pressure (mm Hg) 175 (160–190) 175 (160–190)
Maximum perceived effort (Borg) 16 (15–19) 17 (15–17)**
Raise in rate pressure product 10,560 (8,750–12,870) 10,500 (8,000–13,140)
% of Patients
Chest pain during exercise 42 32***
No ST-depression $1 mV 38 53***
1–2 leads with ST depression 22 16*
$3 leads with ST depression 40 31**
% of Patients receiving treatment at ET
Beta-blockers 80 82
Calcium inhibitors 32 39*
Nitrates 61 63
Digitalis 5 7
Raise in rate pressure product 5 heart rate 3 systolic blood pressure at peak load 2 heart rate 3 systolic blood pressure at rest. *p , 0.05; **p , 0.01; ***p , 0.001.
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perform an early ET thus belong to a high-risk group and
should be treated accordingly.
Exercise test. Among patients who performed the ET,
women reached the expected maximum workload with the
same increase in rate-pressure product but with a higher
perceived effort, with less ST-depression and less chest pain,
compared to men. Thus, it seems that women, despite being
older, performed an adequate ET but with fewer signs of
ischemia. These findings indicate a female population more
healthy than the male population.
As with TnT, the ET was able to identify a low-risk
group among women, but not among men (1% vs. 8%
cardiac death/MI during six months). In the high-risk
response group, women and men had an event rate of 19%
and 20%, respectively, which is high despite optimal med-
ication with beta-blockers and aspirin. Very few, however,
used statins as the study was completed before the publica-
tion of the 4S-study (23). The rate of revascularization at six
months was also quite high, partly because the ET in some
cases influenced the decision to catheterize the patient. In
this direct comparison between women and men with
unstable CAD, performed during the same time period with
the same inclusion/exclusion criteria and medication, we
found that the ET tended to be of even higher prognostic
value in women than in men, which to our knowledge has
not been described previously.
Myocardial marker troponin T. The median TnT maxi-
mum did not differ between the ET and non-ET groups,
but women did have lower median TnT values than men.
Even so, there were more patients with high TnT levels in
Figure 2. (A) Cumulative risk and time of occurrence of cardiac death or myocardial infarction (MI) in groups based on exercise test
findings. (B) Cumulative risk and time of occurrence of cardiac death or myocardial infarction (MI) in groups based on maximal troponin
T levels during the first 24 h (mg/liter).
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the non-ET group compared to the ET group (17% vs. 12%
with TnT .3.0 mg/liter), this again indicating a sicker
patient group. As the majority of the patients had TnT
levels exceeding the decision level for MI, TnT seems to be
a poor sole-selection criteria for high-risk patients in this
type of population of unstable CAD patients admitted to
hospital with ST-T-changes on the resting ECG. It was not
possible to find a real low-risk group among men (event rate
9%), in contrast to women (1%), again reflecting the
differences between the sexes even in such a seemingly
homogeneous population as in our study.
Combination of exercise test and troponin T. Combin-
ing the results from the ET and the TnT values we found it
possible to find a small low-risk group even among men,
with an event rate of 3% (n 5 1) during follow-up. The
combination also revealed a small population with a high
risk (31% and 26% events in women and men, respectively).
The major part of the population, however, consisted of
patients with an intermediate risk where we do not, as yet,
have a satisfactory risk indicator.
Gender differences. Both tests enabled identification of
low-, intermediate-, and high-risk groups regarding cardiac
death in both women and men. Both intermediate-risk and
high-risk groups identified by ET or TnT regarding cardiac
death or MI also had similar female and male event rates.
Among men, however, there were difficulties in identifying
a true low-risk group regarding the combined end point
cardiac death or MI. Only when combining the ET and
TnT values was it possible to identify a group with a
relatively low risk (3%). This group, however, was small
(n 5 34), indicating that the men constituted a relatively
homogeneous high-risk population. Among the women it
was possible to identify a low-risk group with either ET or
TnT. When combining the two methods we were able to
identify a group with no death or MI during follow-up.
These results indicate a healthier female population.
In contrast, the women were older, more often had
previous congestive heart disease, and used more diuretics,
three well-known indicators of a worse prognosis. Further-
more, the intermediate- and high-risk groups identified by
either TnT or the ET had similar event rates among women
and men. The female population therefore seems to be more
heterogeneous than the male population, most probably due
to a higher proportion of female patients with no or less
serious atherosclerosis in their coronary arteries, as is usually
the case when comparing female populations with CAD to
similar male populations (24,25).
Thus, it seems that the criteria used to identify unstable
CAD patients in this study (history of angina and ST-T
changes on the ECG taken while at rest) correctly identify
a high-risk population among men, while the specificity
among women is somewhat lower. In men it can be
discussed whether or not further risk stratification is justi-
fied. In the female population, however, risk stratification
with TnT and an early symptom-limited ET can identify a
low-risk group, and these women can be assured of a good
prognosis. With the development of more sensitive TnT
tests with better discrimination of the very low values it
might be possible to improve the value of this test for risk
stratification among both men and women.
Figure 3. (A–C) Six-month risk for cardiac death or myocardial
infarction (MI) in relation to maximal troponin T levels during the
first 24 h and exercise test response. No ET 5 No exercise test
group. Patients with events before performed or planned ET are
excluded.
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Study limitations. The study population consisted of men
and women with a high probability of CAD. The results
may not be applicable to patient populations with low
pretest probability such as patients with chest pain syn-
dromes at large and no changes on the ECG taken while at
rest.
Conclusions. We found that male and female patients who
were not able to perform the early ET constituted a
high-risk group. In the intermediate- and high-risk groups
defined by ET results or TnT, both women and men had
the same high event rate of death or MI. We found women
on the whole to be older, with more previous cardiovascular
disease but paradoxically with less ischemia and fewer
coronary events. This paradox was easier to understand as
we found it possible to identify women with very little risk
for a coronary event. This was possible with both the ET
and TnT levels and especially a combination of these
indicating that the female population was more heteroge-
neous, with a higher proportion of patients with no or mild
CAD. Among the men, only the combination of ET and
TnT could identify a group with a low risk for subsequent
death or MI, possibly because of a higher likelihood of
disease. By this direct comparison between men and women
from the same population with a high pretest likelihood of
disease, it is possible to conclude that both TnT and the
early ET are at least as useful as prognostic risk indicators in
women as they are in men.
Reprint requests and correspondence: Dr. Kåge Sa¨fstro¨m, De-
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